CLINICAL ROLE -
Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
CDC: COVID-19 Vaccines Protect Against Delta Variant
Study results show that individuals who are unvaccinated are 5 to 7 times more likely to seek medical care because of the predominant strain of the coronavirus.
FDA Grants Fast Track for New Acute Myeloid Leukemia Treatment
VOR33 aims to protect an individual’s healthy cells from anti-CD33 therapies and replace standard care transplants.
Phase 3 Trials Show Benefits of Albuterol, Budesonide Drug
PT0271 improved lung function and reduced the risk of exacerbations in individuals with asthma.
Samsung Bioepis Announces Results of Phase 3 Breast Cancer Treatment
The results of a 5-year follow-up study comparing trastuzumab (Ontruzant) and reference medicine trastuzumab show comparable cardiac safety profiles and long-term efficacy.
Alzheimer Centers in North Carolina, Texas Join NIH Network
The National Institutes of Health grants each entity $14.8 million in funding over the course of 5 years to conduct research into the progressive disease.
Autoimmune Antibodies May Predict COVID-19 Severity
These special immune system defense molecules help show which individuals are most at risk of needing intensive care and need to be monitored more closely, new study results show.
EANO, ESMO Release Joint Guidelines for Brain Metastases Treatment
The European Association of Neuro-Oncology and the European Society for Medical Oncology published recommendations related to parenchymal brain metastases.
New AI Program Identifies Lung Cancer
New artificial intelligence tool can identify tumors at a 97% rate, a year before other methods can diagnose it.
Imfinzi Shows Significant Survival Benefit in Phase 3 Trial for Non-Small Cell Lung Cancer
Results from POSEIDON, a randomized open label, phase 3 trial, showed that patients administered 5 cycles of tremelimumab plus durvalumab and chemotherapy over 16 weeks experienced a 23% reduction in the risk of death compared with various chemotherapy options.
Neighborhood Inequalities Lead to Lower COVID-19 Vaccination Rates
Results of a new study show that the vaccines seldomly reach the area that were heavily affected by the pandemic, because of ethnic, racial, and socioeconomic disparities.
Individuals With Diabetes Develop More Severe COVID-19 Symptoms
The results of a new study show that when coronavirus-infected diabetic mice were injected with an interferon beta, SETDB2 increased and helped decrease the inflammatory cytokines.
Main Prostate Cancer Risk Calculators Adjust to Different Populations
Calibrations for the European Randomized Study on Prostate Cancer and Prostate Cancer Prevention Trial predictors can forecast cases across different groups than originally targeted.
Study: Lymph Nodes Supply Body With T Cells to Attack Cancer
Investigators used a new animal model to determine how the stem-like T cell can survive and what it looks like over the course of several months of tumor growth.
Circadian System Plays Role in Asthma Severity
A new study explores why individuals who suffer most from the condition have the worse symptoms at night.
Prostate Cancer Awareness Month Highlights Importance of Regular Screening
Prostate cancers grow slowly and rarely cause any health problems, so without regular screening, it is more difficult to identify any cancer in the prostate.
New Regulatory Regions May Advance Genomics-Driven Medicine
The results of a new study show a new view of genetic regulation by uncovering how genes and disease are related.
Leaky Heart Valves May Cause Maternal Complications
Although the cardiovascular condition was thought to be benign, the disease could put pregnant women at greater risk for serious complications during childbirth.
2 New Liquid Biopsy Tests May Identify Different Cancers
Study results show that blood and urine exams can potentially pinpoint and track bladder malignancies and nerve tumors.
Cells Exposed to Common Cold Enhance Immune Response to SARS-CoV-2
The results of a new study show that exposure to the viruses produces a protective ‘universal coronavirus’ memory.
HPV Vaccination Is Expected to Reduce Mouth and Throat Cancers Starting in 2045
The results of a new study show that immunizations may help prevent malignancies in individuals aged 36 to 45 years.
Clinical Outcomes of CAP Are Similar for Immunocompromised, Non-Immunocompromised
The results of a study show that with proper antibiotic treatments and therapy, clinical outcomes for those with community-acquired pneumonia do not differ.
Epilepsy Brain Implant Does Not Change Individuals’ Personalities
Study results show that these personalized treatments adjust based on cerebral function through electric pulses.
Blood Test Identifies Subgroup of Individuals With iMCD Who Will Respond to Treatment
Investigators find a precision medicine that can identify those with the rare disorder who may benefit from FDA-approved siltuximab.
Anti-Viral Agents Can Eradicate COVID-19 With B-Cell Recovery, Study Results Show
Convalescent plasma, IVIG, and remdesivir have successfully helped immunocompromised patients recover from the virus.
Decarceration Could Lead to Decrease of Outbreaks
The results of a new study show that stopping jailing individuals may be linked to benefits to community-wide and global public health.
Where Someone Lives May Impact Longevity of Life
New evidence shows that moving to urban areas in the Midwest or either coast could increase the longevity of an individual’s life.
Study Results Show COVID-19 Linked to Decline in Kidney Function
Research shows that individuals who had either a severe or mild case of the virus had an increased risk of kidney damage and disease.
Study: Lack of Green, Blue Spaces in Urban Communities Negatively Impacts Quality of Life for Those With COPD
Study shows the benefit of green and blue spaces for individuals with COPD living in urban communities.
Cocoa Supplements, Green Tea Extract Seen Improving Survival Rate of Mice
The results of a recent Aging-US study show that these additives provide anti-inflammatory and neuroprotective glial subpopulation benefits.
Moderna Submits to FDA Initial Data for COVID-19 Booster Shot, Showing Efficacy Against All COVID-19 Variants
Following a phase 2 study, Moderna submitted initial data to the FDA for the approval of its COVID-19 booster shot that would be administered 6 months after an individual’s second dose.
2 Clarke Drive Cranbury, NJ 08512